$2.14
At close: Nov 21, 3:57 PM EDT
Comments
Loading...
Eagle Pharmaceuticals (OTC:EGRX) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Eagle Pharmaceuticals (EGRX)?
The most recent guidance for Eagle Pharmaceuticals (EGRX) was reported on September 7, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $4.40 to $4.70, compared to the estimated EPS of $4.58. Additionally, Eagle Pharmaceuticals forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.